Effects of different fibrinogen concentrations on blood loss and coagulation parameters in a pig model of coagulopathy with blunt liver injury
Open Access
- 14 April 2010
- journal article
- Published by Springer Nature in Critical Care
- Vol. 14 (2) , R62
- https://doi.org/10.1186/cc8960
Abstract
Introduction: The early application of fibrinogen could potentially reverse haemodilution-induced coagulopathy, although the impact of varying concentrations of fibrinogen to reverse dilutional coagulopathy has not been studied in vivo. We postulated that fibrinogen concentration is correlated with blood loss in a pig model of coagulopathy with blunt liver injury. Methods: Coagulopathy was induced in 18 anaesthetized pigs (32 ± 1.6 kg body weight) by replacing 80% of blood volume with hydroxyethylstarch 130/0.4 and Ringer's lactated solution, and re-transfusion of erythrocytes. Animals were randomly assigned to receive either 70 mg kg-1 (F-70) or 200 mg kg-1 (F-200) fibrinogen or placebo before inducing blunt liver injury using a force of 225 ± 26 Newton. Haemodynamics, coagulation parameters and blood loss were monitored for 2 hours. After death, histological examination of internal organs was performed to assess the presence of emboli and the equality of liver injury. Results: Plasma dilution caused severe coagulopathy. Measured by thromboelastography fibrinogen restored coagulation dose-dependently. Total blood loss was significantly lower and survival better in both fibrinogen groups as compared to controls (P < 0.05). Between the F-70 (1317 ± 113 ml) and the F-200 group (1155 ± 232 ml) no significant difference in total blood loss could be observed, despite improved coagulation parameters in the F-200 group (P < 0.05). Microscopy revealed even injury pattern and no (micro) thrombi for either group. Conclusions: Restoring fibrinogen with 70 or 200 mg kg-1 after severe dilutional coagulopathy safely improved coagulation and attenuated blood loss after experimental blunt liver trauma. The higher dosage of fibrinogen was not associated with a further reduction in blood loss.Keywords
This publication has 40 references indexed in Scilit:
- Animal model and clinical evidence indicating low thrombogenic potential of fibrinogen concentrate (Haemocomplettan P)Blood Coagulation & Fibrinolysis, 2009
- Bleeding management with fibrinogen concentrate targeting a high-normal plasma fibrinogen level: a pilot studyBritish Journal of Anaesthesia, 2009
- Prophylactic fibrinogen infusion reduces bleeding after coronary artery bypass surgeryThrombosis and Haemostasis, 2009
- Effects of plasma dilution on tissue factor–induced thrombin generation and thromboelastography: partly compensating role of plateletsTransfusion, 2008
- The Coagulopathy of Trauma: A Review of MechanismsJournal of Trauma: Injury, Infection & Critical Care, 2008
- Increased thrombin generation and fibrinogen level after therapeutic plasma transfusion: Relation to bleedingThrombosis and Haemostasis, 2008
- In Vivo Bleeding Time and In Vitro Thrombelastography Measurements are Better Indicators of Dilutional Hypothermic Coagulopathy Than Prothrombin TimeJournal of Trauma: Injury, Infection & Critical Care, 2007
- Basic aspects of bypassing agentsHaemophilia, 2006
- Positive Feedbacks of CoagulationArteriosclerosis, Thrombosis, and Vascular Biology, 2005
- Effects of coagulation factor deficiency on plasma coagulation kinetics determined via thrombelastography®: critical roles of fibrinogen and factors II, VII, X and XIIActa Anaesthesiologica Scandinavica, 2005